tiprankstipranks
Teva Pharmaceutical Industries Limited (DE:TEV)
NYSE:TEV
Germany Market
TEV
Teva Pharmaceutical
RESEARCH TOOLSreports

Teva Pharmaceutical (TEV) Stock News & Sentiment

36 Followers
Corcept Rockets 48% after FDA Lifyorli Approval — What Does This Mean for CORT Stock?
Premium
Market News
Corcept Rockets 48% after FDA Lifyorli Approval — What Does This Mean for CORT Stock?
18d ago
CORT
TEVA
Enphase, AST SpaceMobile, AppLovin, ConocoPhillips, Teva Shock
Premium
Weekend Updates
Enphase, AST SpaceMobile, AppLovin, ConocoPhillips, Teva Shock
23d ago
APP
COP
Corcept Therapeutics Stock Crashes 21% after Patent Defeat to Teva
Premium
Market News
Corcept Therapeutics Stock Crashes 21% after Patent Defeat to Teva
2M ago
CORT
TEVA
Teva Buy Rating Reinforced by Strong TL1a Phase 2 Data and $3 Billion Duvakitug Peak Sales Outlook
Premium
Ratings
Teva Buy Rating Reinforced by Strong TL1a Phase 2 Data and $3 Billion Duvakitug Peak Sales Outlook
2M ago
TEVA
Teva’s Sustainability Disclosures Face Rising Legal and Investor Risk Amid Global Compliance Demands
Premium
Company Announcements
Teva’s Sustainability Disclosures Face Rising Legal and Investor Risk Amid Global Compliance Demands
2M ago
TEVA
Teva Earnings Call: Innovation Offsets Generics and One-Offs
Premium
Company Announcements
Teva Earnings Call: Innovation Offsets Generics and One-Offs
2M ago
TEVA
Options Volatility and Implied Earnings Moves This Week, January 26 – January 30, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, January 26 – January 30, 2026
3M ago
T
BA
More DE:TEV News >

TEV News on the Web

AMRX: 3 Growth Drivers Behind Amneal's 2026 Outlook
Zacks
Neutral
Is AMRX Stock Undervalued? Sales Multiple, Target, Upside
Zacks
Neutral
Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing
Zacks
Neutral
Should You Buy, Sell or Hold JNJ Stock Ahead of Q1 Earnings?
Zacks
Bearish
Analysts Are Bullish on These Healthcare Stocks: InflaRx (IFRX), Teva Pharmaceutical (TEVA)
TipRanks News
Neutral
Teva price target raised to $42 from $38 at BofA
TipRanks News
Bullish
Weekly Buzz: SPRY Gains FDA Nod; EU Expands Kerendia Label; LLY Acquires CNTA; BIIB Snaps Up APLS
rttnews
Neutral
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Nuvation Bio (NUVB) and Argenx Se (ARGX)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
DE:TEV
Sector Average
Media Buzz
This Week7 articles
Weekly Average6.75 articles
News Sentiment
This Week50%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:TEV’s Media Buzz Sentiment?
7 articles about DE:TEV were published this week. In an average week, 6.75 articles are published.
    What is DE:TEV’s weekly average amount of articles?
    In an average week, 6.75 articles about DE:TEV are published.
      What is DE:TEV’s News Sentiment?
      50% of articles about DE:TEV were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        STAAStaar Surgical
        IVVDInvivyd
        SLPSimulations Plus
        REPLReplimune Group
        Showing the stocks with the most bullish news sentiment over the past week